Strides Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE939A01011
  • NSEID: STAR
  • BSEID: 532531
INR
877.75
-7.9 (-0.89%)
BSENSE

Dec 05

BSE+NSE Vol: 70.26 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
92.16
91.90
90.30
89.79
89.68
89.56
Share Warrants & Outstandings
Total Reserve
2,459.16
2,030.57
2,102.54
2,266.99
2,682.26
2,432.13
Shareholder's Funds
2,551.83
2,125.57
2,212.26
2,359.23
2,776.66
2,527.42
Minority Interest
34.63
-53.86
-39.38
24.09
37.34
67.24
Long-Term Borrowings
571.24
671.50
1,139.79
835.62
882.58
603.91
Secured Loans
558.47
618.40
1,040.81
744.86
873.43
601.79
Unsecured Loans
12.78
53.10
98.98
90.77
9.15
2.12
Deferred Tax Assets / Liabilities
-149.78
-227.00
-220.46
-179.43
-151.87
-177.76
Other Long Term Liabilities
66.2
85.32
217.55
245.25
466.34
323.54
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
113.94
91.63
73.42
64.28
67.41
63.95
Total Non-Current Liabilities
601.61
621.44
1,210.30
965.72
1,264.45
813.65
Current Liabilities
Trade Payables
1,032.50
851.59
982.34
1,071.52
1,178.62
797.75
Other Current Liabilities
253.44
213.12
250.70
261.19
411.69
392.81
Short Term Borrowings
1,224.37
1,743.03
1,634.67
1,956.34
1,023.84
1,228.78
Short Term Provisions
81.21
71.53
122.49
122.62
124.19
125.52
Total Current Liabilities
2,591.52
2,879.26
2,990.20
3,411.68
2,738.35
2,544.86
Total Liabilities
5,779.59
5,572.41
6,373.39
6,760.71
6,816.80
5,953.16
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
2,739.23
2,703.68
3,057.95
2,991.01
2,584.29
2,258.59
Less: Accumulated Depreciation
920.62
940.00
944.08
833.45
636.14
479.90
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
1,818.60
1,763.68
2,113.87
2,157.57
1,948.15
1,778.69
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
99.65
79.88
48.26
56.23
227.60
148.06
Intangible assets under development
107.11
82.02
102.72
234.85
219.77
264.89
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
350.88
208.83
451.54
553.51
666.23
503.24
Long Term Loans & Advances
137.42
252.64
214.60
208.00
185.25
214.61
Other Non Current Assets
97.50
126.87
14.49
12.84
549.58
424.41
Total Non-Current Assets
2,680.68
2,603.41
3,130.03
3,398.88
3,999.57
3,581.05
Current Assets Loans & Advances
Current Investments
69.50
105.76
50.84
0.00
99.41
118.97
Inventories
1,277.57
1,126.24
1,146.51
1,173.80
1,200.70
782.54
Sundry Debtors
1,202.94
1,141.87
1,299.40
1,207.30
1,106.86
931.69
Cash and Bank
136.78
191.17
315.96
187.35
179.76
237.10
Other Current Assets
272.72
198.96
261.94
642.12
94.48
80.88
Short Term Loans and Advances
139.39
205.00
168.71
151.26
136.02
220.93
Total Current Assets
3,098.91
2,969.00
3,243.36
3,361.83
2,817.23
2,372.11
Net Current Assets (Including Current Investments)
507.39
89.74
253.16
-49.84
78.89
-172.75
Total Current Assets Excluding Current Investments
3,029.41
2,863.24
3,192.52
3,361.83
2,717.82
2,253.14
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
5,779.59
5,572.41
6,373.39
6,760.71
6,816.80
5,953.16
Contingent Liabilities
98.09
474.83
632.08
1,174.80
841.68
2,378.87
Total Debt
0.00
2,414.53
2,774.46
2,791.96
1,906.45
1,832.68
Book Value per share (adjusted)
276.88
101.347028561913
106.522177331008
115.1152905708
135.675661463765
123.655819741812
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is -25.63% vs -12.97% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is -22.41% vs -60.78% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 4.05% vs -14.73% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 68.02% vs -53.75% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 4.38% vs -8.46% in Mar 2024

Compare Balance Sheet Results of Strides Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
92.16
45.32
46.84
103.35%
Share Warrants & Outstandings
Total Reserve
2,459.16
2,421.60
37.56
1.55%
Shareholder's Funds
2,551.83
2,466.91
84.92
3.44%
Minority Interest
34.63
22.47
12.16
54.12%
Long-Term Borrowings
571.24
0.00
571.24
0.00%
Secured Loans
558.47
0.00
558.47
0.00%
Unsecured Loans
12.78
0.00
12.78
0.00%
Deferred Tax Assets / Liabilities
-149.78
3.66
-153.44
-4,192.35%
Other Long Term Liabilities
66.20
263.33
-197.13
-74.86%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
113.94
5.92
108.02
1,824.66%
Total Non-Current Liabilities
601.61
272.91
328.70
120.44%
Current Liabilities
Trade Payables
1,032.50
305.70
726.80
237.75%
Other Current Liabilities
253.44
147.11
106.33
72.28%
Short Term Borrowings
1,224.37
23.09
1,201.28
5,202.60%
Short Term Provisions
81.21
1.45
79.76
5,500.69%
Total Current Liabilities
2,591.52
477.34
2,114.18
442.91%
Total Liabilities
5,779.59
3,239.63
2,539.96
78.40%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2,739.23
1,039.28
1,699.95
163.57%
Less: Accumulated Depreciation
920.62
364.25
556.37
152.74%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1,818.60
675.03
1,143.57
169.41%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
99.65
9.00
90.65
1,007.22%
Intangible assets under development
107.11
18.11
89.00
491.44%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
350.88
0.00
350.88
0.00%
Long Term Loans & Advances
137.42
26.27
111.15
423.11%
Other Non Current Assets
97.50
0.17
97.33
57,252.94%
Total Non-Current Assets
2,680.68
1,035.51
1,645.17
158.88%
Current Assets Loans & Advances
Current Investments
69.50
0.74
68.76
9,291.89%
Inventories
1,277.57
845.52
432.05
51.10%
Sundry Debtors
1,202.94
540.04
662.90
122.75%
Cash and Bank
136.78
704.21
-567.43
-80.58%
Other Current Assets
272.72
44.67
228.05
510.52%
Short Term Loans and Advances
139.39
68.94
70.45
102.19%
Total Current Assets
3,098.91
2,204.12
894.79
40.60%
Net Current Assets (Including Current Investments)
507.39
1,726.78
-1,219.39
-70.62%
Total Current Assets Excluding Current Investments
3,029.41
2,203.38
826.03
37.49%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
5,779.59
3,239.63
2,539.96
78.40%
Contingent Liabilities
98.09
0.00
98.09
0.00%
Total Debt
0.00
23.09
-23.09
-100.00%
Book Value per share (adjusted)
276.88
54.44
222.44
408.60%
Annual - Borrowings
Borrowings 1,795.61 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -25.63% vs -12.97% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 66.20 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -22.41% vs -60.78% in Mar 2024

Annual - Fixed Assets
Fixed Assets 1,918.25 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.05% vs -14.73% in Mar 2024

Annual - Investments
Investments 350.88 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 68.02% vs -53.75% in Mar 2024

Annual - Current Assets
Current Assets 3,098.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.38% vs -8.46% in Mar 2024